对儿科 HCM 风险评分预测严重室性心律失常的独立外部评估

IF 2.3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
M. Wilkin, V. Waldmann
{"title":"对儿科 HCM 风险评分预测严重室性心律失常的独立外部评估","authors":"M. Wilkin,&nbsp;V. Waldmann","doi":"10.1016/j.acvd.2024.07.012","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Sudden cardiac death (SCD) is the most common cause of death in childhood hypertrophic cardiomyopathy (HCM). Recently, two risk scores have been developed to estimate the 5-year risk of SCD.</p></div><div><h3>Objective</h3><p>We aimed to assess their respective performances in an independent cohort of primary prevention children with HCM.</p></div><div><h3>Methods</h3><p>All patients with HCM<!--> <!-->&lt;<!--> <!-->18-year-old from a single-center were retrospectively included between 2003 and 2023. Secondary and syndromic causes of HCM were excluded as well as children with inaugural sustained ventricular arrythmias. HCM Risk-Kids and PRIMaCY risk scores were calculated at diagnosis and during follow-up. The primary composite outcome included sustained ventricular arrhythmia, appropriate ICD therapy, aborted cardiac arrest, or SCD.</p></div><div><h3>Results</h3><p>Hundred primary prevention children were included (mean age 7.1<!--> <!-->±<!--> <!-->5.6<!--> <!-->years, 59.0% males), with a mean follow-up of 8.6<!--> <!-->±<!--> <!-->5.5<!--> <!-->years.13 (13.0%) patients experienced the primary composite outcome. When only considering events during the 5 first years, Harrel's C index was 0.52 (95% CI: 0.27–0.77) for HCM Risk-Kids (≥<!--> <!-->6%) and 0.70 (95% CI: 0.59–0.80) for PRIMaCY (&gt;<!--> <!-->8.3%), with 1 patient potentially treated by ICD for every 25 ICDs implanted for HCM Risk Kids and 1 for every 14 ICDs implanted for PRIMaCY. When risk scores were repeated and all primary outcomes during follow-up considered, all events except one (93.2%) were correctly identified using both risk scores, with 1 patient potentially treated by ICD for every 5.6 ICDs implanted for HCM Risk Kids and 1 for every 5.3 ICDs implanted for PRIMaCY. Among 44 (44.0%) patients implanted with an ICD, all primary prevention patients who had<!--> <!-->≥<!--> <!-->one appropriate ICD therapy during follow-up had HCM Risk-Kids<!--> <!-->≥<!--> <!-->6% and PRIMaCY<!--> <!-->&gt;<!--> <!-->8.3% at implantation.</p></div><div><h3>Conclusion</h3><p>Our findings suggest imperfect discrimination between low and high-risk HCM patients using these two risk scores. The performance or risk scores was substantially improved by periodic re-assessment during follow-up.</p></div>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Independent external evaluation of pediatric HCM Risk Scores in predicting severe ventricular arrhythmias\",\"authors\":\"M. Wilkin,&nbsp;V. Waldmann\",\"doi\":\"10.1016/j.acvd.2024.07.012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Sudden cardiac death (SCD) is the most common cause of death in childhood hypertrophic cardiomyopathy (HCM). Recently, two risk scores have been developed to estimate the 5-year risk of SCD.</p></div><div><h3>Objective</h3><p>We aimed to assess their respective performances in an independent cohort of primary prevention children with HCM.</p></div><div><h3>Methods</h3><p>All patients with HCM<!--> <!-->&lt;<!--> <!-->18-year-old from a single-center were retrospectively included between 2003 and 2023. Secondary and syndromic causes of HCM were excluded as well as children with inaugural sustained ventricular arrythmias. HCM Risk-Kids and PRIMaCY risk scores were calculated at diagnosis and during follow-up. The primary composite outcome included sustained ventricular arrhythmia, appropriate ICD therapy, aborted cardiac arrest, or SCD.</p></div><div><h3>Results</h3><p>Hundred primary prevention children were included (mean age 7.1<!--> <!-->±<!--> <!-->5.6<!--> <!-->years, 59.0% males), with a mean follow-up of 8.6<!--> <!-->±<!--> <!-->5.5<!--> <!-->years.13 (13.0%) patients experienced the primary composite outcome. When only considering events during the 5 first years, Harrel's C index was 0.52 (95% CI: 0.27–0.77) for HCM Risk-Kids (≥<!--> <!-->6%) and 0.70 (95% CI: 0.59–0.80) for PRIMaCY (&gt;<!--> <!-->8.3%), with 1 patient potentially treated by ICD for every 25 ICDs implanted for HCM Risk Kids and 1 for every 14 ICDs implanted for PRIMaCY. When risk scores were repeated and all primary outcomes during follow-up considered, all events except one (93.2%) were correctly identified using both risk scores, with 1 patient potentially treated by ICD for every 5.6 ICDs implanted for HCM Risk Kids and 1 for every 5.3 ICDs implanted for PRIMaCY. Among 44 (44.0%) patients implanted with an ICD, all primary prevention patients who had<!--> <!-->≥<!--> <!-->one appropriate ICD therapy during follow-up had HCM Risk-Kids<!--> <!-->≥<!--> <!-->6% and PRIMaCY<!--> <!-->&gt;<!--> <!-->8.3% at implantation.</p></div><div><h3>Conclusion</h3><p>Our findings suggest imperfect discrimination between low and high-risk HCM patients using these two risk scores. The performance or risk scores was substantially improved by periodic re-assessment during follow-up.</p></div>\",\"PeriodicalId\":55472,\"journal\":{\"name\":\"Archives of Cardiovascular Diseases\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Cardiovascular Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S187521362400233X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Cardiovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S187521362400233X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

导言心脏性猝死(SCD)是儿童肥厚型心肌病(HCM)最常见的死因。我们的目标是在一个独立的 HCM 患儿一级预防队列中评估这两个评分的各自性能。方法回顾性纳入 2003 年至 2023 年期间来自一个单一中心的所有 18 岁 HCM 患者。方法回顾性纳入 2003 年至 2023 年期间来自单一中心的所有 18 岁 HCM 患者,并排除继发性和综合征性 HCM 病因,以及患有就诊时持续性室性心律失常的儿童。在诊断时和随访期间计算 HCM Risk-Kids 和 PRIMaCY 风险评分。结果纳入了 100 名一级预防儿童(平均年龄为 7.1 ± 5.6 岁,59.0% 为男性),平均随访时间为 8.6 ± 5.5 年。如果只考虑最初 5 年的事件,HCM Risk-Kids 的 Harrel's C 指数为 0.52(95% CI:0.27-0.77)(≥ 6%),PRIMaCY 的 Harrel's C 指数为 0.70(95% CI:0.59-0.80)(> 8.3%),HCM Risk Kids 每植入 25 个 ICD,就有 1 名患者可能接受 ICD 治疗,PRIMaCY 每植入 14 个 ICD,就有 1 名患者可能接受 ICD 治疗。当重复进行风险评分并考虑随访期间的所有主要结果时,除一个事件(93.2%)外,使用两种风险评分都能正确识别所有事件,HCM Risk Kids 每植入 5.6 个 ICD 就有 1 名患者可能接受 ICD 治疗,PRIMaCY 每植入 5.3 个 ICD 就有 1 名患者可能接受 ICD 治疗。在 44 名(44.0%)植入 ICD 的患者中,所有在随访期间接受过≥ 一次适当 ICD 治疗的一级预防患者在植入时 HCM Risk-Kids ≥ 6%,PRIMaCY > 8.3%。在随访期间进行定期再评估可大大提高风险评分的性能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Independent external evaluation of pediatric HCM Risk Scores in predicting severe ventricular arrhythmias

Introduction

Sudden cardiac death (SCD) is the most common cause of death in childhood hypertrophic cardiomyopathy (HCM). Recently, two risk scores have been developed to estimate the 5-year risk of SCD.

Objective

We aimed to assess their respective performances in an independent cohort of primary prevention children with HCM.

Methods

All patients with HCM < 18-year-old from a single-center were retrospectively included between 2003 and 2023. Secondary and syndromic causes of HCM were excluded as well as children with inaugural sustained ventricular arrythmias. HCM Risk-Kids and PRIMaCY risk scores were calculated at diagnosis and during follow-up. The primary composite outcome included sustained ventricular arrhythmia, appropriate ICD therapy, aborted cardiac arrest, or SCD.

Results

Hundred primary prevention children were included (mean age 7.1 ± 5.6 years, 59.0% males), with a mean follow-up of 8.6 ± 5.5 years.13 (13.0%) patients experienced the primary composite outcome. When only considering events during the 5 first years, Harrel's C index was 0.52 (95% CI: 0.27–0.77) for HCM Risk-Kids (≥ 6%) and 0.70 (95% CI: 0.59–0.80) for PRIMaCY (> 8.3%), with 1 patient potentially treated by ICD for every 25 ICDs implanted for HCM Risk Kids and 1 for every 14 ICDs implanted for PRIMaCY. When risk scores were repeated and all primary outcomes during follow-up considered, all events except one (93.2%) were correctly identified using both risk scores, with 1 patient potentially treated by ICD for every 5.6 ICDs implanted for HCM Risk Kids and 1 for every 5.3 ICDs implanted for PRIMaCY. Among 44 (44.0%) patients implanted with an ICD, all primary prevention patients who had  one appropriate ICD therapy during follow-up had HCM Risk-Kids  6% and PRIMaCY > 8.3% at implantation.

Conclusion

Our findings suggest imperfect discrimination between low and high-risk HCM patients using these two risk scores. The performance or risk scores was substantially improved by periodic re-assessment during follow-up.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Archives of Cardiovascular Diseases
Archives of Cardiovascular Diseases 医学-心血管系统
CiteScore
4.40
自引率
6.70%
发文量
87
审稿时长
34 days
期刊介绍: The Journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles and editorials. Topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信